Last reviewed · How we verify

NCT04966078

Treatment of Mild and Moderate Cases of Gynaecomastia

Status unknown NA Last updated 19 July 2021
What this trial tests

NA trial testing liposuction in Gynecomastia in 40 participants. Status unknown.

Timeline
1 January 2021
Primary endpoint
1 January 2022
1 February 2022

Quick facts

Lead sponsorSohag University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 January 2021
Primary completion1 January 2022
Estimated completion1 February 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 18 to 60, male only, with Gynecomastia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare liposuction and periareolar surgical excision in mild and moderate cases of gynecomastia as regard cosmosis, complications, patient satisfaction, operation time, and hospital stay. This study will be carried out on patients with gynecomastia presented to the Plastic Surgery Department, Sohag University, in the period between January 2021 to January 2022 as a retrospective and prospective study. Patients will be divided into 2 groups: group A treated with suction-assisted liposuction. group B treated with peri-areolar surgical excision. Each group contains 20 patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of liposuction

Trials testing the same drug.

Other recruiting trials for Gynecomastia

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04966078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing